Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy
Radiotherapy and Oncology, 08/06/09
Wang CY et al. - In a study to evaluate if C-reactive protein (CRP) is an objective biomarker of esophageal cancer (EC) in pts undergoing radiotherapy, it was revealed that pretreatment serum levels of CRP and albumin are objective, easily measurable biomarkers that can be used in combination with conventional staging to accurately predict survival in pts with EC treated with radiotherapy.
Methods- 123 pts undergoing radiotherapy for newly diagnosed EC were enrolled.
- Serum CRP concentration was measured before initiation of treatment.
- The relationship between serum CRP levels and other relevant variables such as body mass index, white blood cell count, platelet count, bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), cholesterol, hemoglobin, and albumin levels was analyzed.
- 81 of 123 pts enrolled (65.9%) had elevated CRP levels (≥5 mg/L).
- 2-yr survival for pts with CRP ≥5 mg/L was 7.8% vs 78.4% for pts with CRP <5 mg/L.
- Hypoalbuminemia (albumin <3.5 g/dL) was also related to shorter survival using univariate analysis.
- Multivariate analysis demonstrated that only higher serum CRP concentration and hypoalbuminemia were independent prognostic indicators for survival of pts with EC.
Related Articles
Association of C-Reactive Protein Levels and Long-Term Survival after Neoadjuvant Therapy and Esophagectomy for Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/03/09
Relevance Score: 67%
Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery
Diseases of the Esophagus, 11/25/09
Relevance Score: 67%
Impact of lymph-node metastasis site in patients with thoracic esophageal cancer
Journal of Surgical Oncology, 11/19/09
Relevance Score: 67%
Detection of metachronous esophageal squamous carcinoma in patients with head and neck cancer with use of transnasal esophagoscopy
Head & Neck, 11/06/09
Relevance Score: 67%
The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period
BMC Cancer, 11/02/09
Relevance Score: 67%
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Projected cancer risks from computed tomographic scans performed in the United States in 2007
Archives of Internal Medicine, 12/15/09
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer
Archives of Internal Medicine, 12/15/09
Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program
Cancer, 12/15/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
Carcinogenesis, 12/15/09
Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: Implication in oxidative stress
Cancer Chemotherapy and Pharmacology, 12/15/09
Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: A pilot study
Medical Oncology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


